Clinical Trial Update: A Study of Conventional 3D Radiation vs. Intensity-Modulated Radiation in Squamous Cell Cancer of the Head and Neck [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing conventional 3D radiation to intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Snippet

Sponsor: Alberta Health services | Conditions: Head and Neck Neoplasms, Squamous Cell Cancer | Phase 2, Phase 3 | Status: WITHDRAWN